Open Access Open Access  Restricted Access Subscription or Fee Access

Herbal Treatment of Lipid Dysfunction: A Review of Procedures Correlated to the Use of Classical Remedy for the Treatment of Dysfunction

Siddharth Bhardwaj, Monika Singh, Sarika Chaudhary, Moumita Barman

Abstract


Abstract

Resolution with review: The developments were made probable by the enhancement in organizational knowledge and augmented aptitude to recognize precise lipid moieties in definite subdomains. Current Discoveries: Lipid dysfunction largely demarcated, mentions to any genetic signaling occasion connecting a lipid envoy that fixes a protein, for example a receptor, kinase, or phosphatase, which in crack arbitrate the possessions of lipids on definite cellular rejoinders. In conclusion, the influence of lipid relations and their significance to cell role has expanded, offering the opportunity for more beneficial targeting with better specificity.

 

Keywords: Cell, signaling, lipids, obesity, biomolecules, kinases, phosphatases.

Citation: Siddharth Bhardwaj, Monika Singh, Sarika Chaudhary, Moumita Barman. Herbal Treatment of Lipid Dysfunction: A Review of Procedures Correlated to the Use of Classical Remedy for the Treatment of Dysfunction. Research & Reviews: A Journal of Pharmacology. 2022; 12(3): 29–33p.


Full Text:

PDF

References


Natesan V, Kim SJ. Lipid Metabolism, Disorders and Therapeutic Drugs–Review. Biomolecules & therapeutics. 2021 Nov 11;29(6):596.

“Lipid Metabolism Disorders.” MedlinePlus, U.S. National Library of Medicine, https://medlineplus.gov/lipidmetabolismdisorders.html.

Chung KW. Advances in understanding of the role of lipid metabolism in aging. Cells. 2021 Apr 13;10(4):880.

Kao YC, Ho PC, Tu YK, Jou IM, Tsai KJ. Lipids and Alzheimer’s disease. International journal of molecular sciences. 2020 Feb 22;21(4):1505.

Shattat GF. A review article on hyperlipidemia: types, treatments and new drug targets. Biomedical and Pharmacology Journal. 2015 May 3;7(1):399-409.

Soppert J, Lehrke M, Marx N, Jankowski J, Noels H. Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting. Advanced drug delivery reviews. 2020 Jan 1; 159:4-33.

Dong J, Yang S, Zhuang Q, Sun J, Wei P, Zhao X, Chen Y, Chen X, Li M, Wei L, Chen C. The associations of lipid profiles with cardiovascular diseases and death in a 10-year prospective cohort study. Frontiers in Cardiovascular Medicine. 2021;8.

Bhargava S, de la Puente-Secades S, Schurgers L, Jankowski J. Lipids and lipoproteins in cardiovascular diseases: a classification. Trends in Endocrinology & Metabolism. 2022 Mar 31.

Chait A, Eckel RH. Lipids, lipoproteins, and cardiovascular disease: clinical pharmacology now and in the future. The Journal of Clinical Endocrinology & Metabolism. 2016 Mar 1;101(3):804–14.

Miller WM, Nori-Janosz KE, Lillystone M, Yanez J, McCullough PA. Obesity and lipids. Current cardiology reports. 2005 Nov;7(6):465–70.

Yan J, Zhao Z, Xia M, Chen S, Wan X, He A, Sheng GD, Wang X, Qian Q, Wang H. Induction of lipid metabolism dysfunction, oxidative stress and inflammation response by tris (1-chloro-2-propyl) phosphate in larval/adult zebrafish. Environment International. 2022 Feb 1;160:107081.

Vekic J, Zeljkovic A, Stefanovic A, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V. Obesity and dyslipidemia. Metabolism. 2019 Mar 1; 92:71–81.

Ayala A, Muñoz MF, Argüelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxidative medicine and cellular longevity. 2014; 2014: 360438.

Sunshine H, Iruela-Arispe ML. Membrane lipids and cell signaling. Current opinion in lipidology. 2017 Oct;28(5):408.

Lord CC, Thomas G, Brown JM. Mammalian alpha beta hydrolase domain (ABHD) proteins: Lipid metabolizing enzymes at the nterface of cell signaling and energy metabolism. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids. 2013 Apr 1;1831(4):792–802.

Kuniyoshi M, Nakamichi R, Carmona SdeM, da Glória MA, Dalboni MA, et al. (2020) Action of Simvastatin on the Attenuation of Inflammation in 3T3-L1 Adipocytes is Related to PPARs Modulation. Eur Exp Biol Vol.10

Mirza AZ, Althagafi II, Shamshad H. Role of PPAR receptor in different diseases and their ligands: Physiological importance and clinical implications. European Journal of Medicinal Chemistry. 2019 Mar 15;166:502–13.

Huang R, Zhang J, Li M, Yan P, Yin H, Zhai S, Zhu X, Hu P, Zhang J, Huang L, Li M. The role of peroxisome proliferator-activated receptors (PPARs) in pan-cancer. PPAR research. 2020 Sep 22;2020.

van Raalte DH, Li M, Pritchard PH, Wasan KM. Peroxisome proliferator-activated receptor (PPAR)-α: a pharmacological target with a promising future. Pharmaceutical research. 2004 Sep;21(9):1531–8.

Bocher V, Chinetti G, Fruchart JC, Staels B. Rôles des "peroxisome proliferator-activated receptors" (PPARs) dans la régulation du métabolisme des lipides et le contrôle de l'inflammation [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control]. J Soc Biol. 2002;196(1):47–52. French. PMID: 12134632.

Fredenrich A, Grimaldi PA. PPAR delta: an uncompletely known nuclear receptor. Diabetes Metab. 2005 Feb;31(1):23–7. doi: 10.1016/s1262–3636(07)70162-3. PMID: 15803109.

Brondani LA, Assmann TS, Duarte GC, Gross JL, Canani LH, Crispim D. The role of the uncoupling protein 1 (UCP1) on the development of obesity and type 2 diabetes mellitus. Arq Bras Endocrinol Metabol. 2012 Jun;56(4):215-25. doi: 10.1590/s0004-27302012000400001. PMID: 22790465.

Ramji DP, Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochemical Journal. 2002 Aug 1;365(3):561–75.

Nerlov C. The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends in cell biology. 2007 Jul 1;17(7):318–24.

Zhong S, Li L, Liang N, Zhang L, Xu X, Chen S, Yin H. Acetaldehyde Dehydrogenase 2 regulates HMG-CoA reductase stability and cholesterol synthesis in the liver. Redox biology. 2021 May 1;41:101919.

Winfried M, Heinrich W. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?. Herz. 2000;25(2):117–25.

Shabana, Shahid, S.U. & Sarwar, S. The abnormal lipid profile in obesity and coronary heart disease (CHD) in Pakistani subjects. Lipids Health Dis 19, 73 (2020).

Fan Q, Xu F, Liang B, Zou X. The anti–obesity effect of traditional Chinese medicine on lipid metabolism. Frontiers in Pharmacology. 2021 Jun 21;12:696603.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2023 Research & Reviews: A Journal of Pharmacology